Loeb & Loeb LLP is proud to sponsor the American Conference Institute's (ACI) 7th Annual Paragraph IV Disputes conference, where partner Mark E. Waddell will be moderating a panel titled "New Developments in Damages Theories and Injunctions Relative to At Risk Launches: Legal and Economic Assessments."
From the conference website:
Now in its seventh iteration, ACI's Paragraph IV Disputes conference is the only event which helps both brand name and generic pharmaceutical companies make sense of changing industry dynamics precipitated by the patent cliff and other factors such as patent reform, regulatory shifts and recent and pending case law. This is the conference that not only sets the standards for Paragraph IV litigation, but also serves as the annual meeting place for the “who’s who” of pharmaceutical patent litigation.
For more information, including how to register, please see the American Conference Institute website.